Literature DB >> 4714960

Effect of intravenous prostaglandin E 2 on platelet function, coagulation, and fibrinolysis.

P W Howie, A A Calder, C D Forbes, C R Prentice.   

Abstract

Prostaglandin E(2) (PGE(2)) was infused intravenously to eight women for the termination of pregnancy and tests of platelet function: coagulation and fibrinolysis were studied before and during the infusion.Platelet adhesiveness, as measured by a cellophane membrane test-cell system, was significantly diminished by PGE(2), a change which was not noted by the glass-bead column technique. The administration of PGE(2) caused more rapid platelet disaggregation following ADP-induced aggregation but had no effect on the platelet count, collagen-induced aggregation, or platelet factor 3 activity. An increase in plasma antithrombin concentration and euglobulin lysis activity was also noted. These results support the concept that prostaglandin E(2) might have a role in the prevention of thrombosis.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4714960      PMCID: PMC477734          DOI: 10.1136/jcp.26.5.354

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  24 in total

1.  Inhibition of platelet energy production and release reaction by PGE1, theophylline and cAMP.

Authors:  S M Wolfe; N R Shulman
Journal:  Biochem Biophys Res Commun       Date:  1970-10-09       Impact factor: 3.575

2.  Platelet aggregation. II. Adenyl cyclase, prostaglandin E1, and calcium.

Authors:  R L Vigdahl; N R Marquis; P A Tavormina
Journal:  Biochem Biophys Res Commun       Date:  1969-10-22       Impact factor: 3.575

3.  Platelet aggregation. I. Regulation by cyclic AMP and prostaglandin E1.

Authors:  N R Marquis; R L Vigdahl; P A Tavormina
Journal:  Biochem Biophys Res Commun       Date:  1969-09-10       Impact factor: 3.575

4.  Relative activity of prostaglandins E1, A1, E2 and A2 on lipolysis, platelet aggregation, smooth muscle and the cardiovascular system.

Authors:  J R Weeks; N C Sekhar; D W Ducharme
Journal:  J Pharm Pharmacol       Date:  1969-02       Impact factor: 3.765

5.  Prostaglandin E 1 and human platelets.

Authors:  R S Elkeles; J R Hampton; M J Harrison; J R Mitchell
Journal:  Lancet       Date:  1969-07-12       Impact factor: 79.321

6.  Fibrin degradation products in normal and abnormal pregnancy and parturition.

Authors:  J Bonnar; J F Davidson; C F Pidgeon; G P McNicol; A S Douglas
Journal:  Br Med J       Date:  1969-07-19

7.  Prostaglandins in platelet aggregation.

Authors:  E Irion; M Blombäck
Journal:  Scand J Clin Lab Invest       Date:  1969-09       Impact factor: 1.713

8.  Influence of prostaglandins E1 and E2 on coagulation of rat blood.

Authors:  J Kloeze
Journal:  Experientia       Date:  1970-03-15

9.  Effect of prostaglandin E1 on platelet behaviour in vitro and in vivo.

Authors:  P R Emmons; J R Hampton; M J Harrison; A J Honour; J R Mitchell
Journal:  Br Med J       Date:  1967-05-20

10.  Thrombo-embolism and increased platelet adhesiveness in post-splenectomy thrombocytosis.

Authors:  J Hirsh; J A McBride; J V Dacie
Journal:  Australas Ann Med       Date:  1966-05
View more
  1 in total

Review 1.  Prostaglandins: pharmacology and clinical application.

Authors:  S M Karim; K Hillier
Journal:  Drugs       Date:  1974       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.